Mustang Bio gets Nasdaq extension until April 12, 2027, to meet minimum bid price requirement
Nasdaq granted Mustang Bio an additional 180 days on October 13, 2026, extending its minimum bid-price compliance deadline to April 12, 2027. The extension follows failure to regain compliance by October 12, 2026, following 30 consecutive business days with closing bids below $1.00. Compliance requires a closing bid of